IP Verse

Ucb Biopharma Srl opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Ucb Biopharma Srl

Patent Number:
EP2784084
Title:
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof
Applicant:
GENENTECH, INC.
Opposition Date:
Apr 23, 2020
Patent Number:
EP2531218
Title:
Immunoglobulin Preparation
Applicant:
CSL BEHRING AG
Opposition Date:
Sep 11, 2019
Patent Number:
EP2282758
Title:
Antibodies And Vaccines For Use In Therapeutic And Diagnostic Methods For Alpha-Synuclein-Related Disorders
Applicant:
BIOARCTIC AB
Opposition Date:
Aug 21, 2019
Patent Number:
EP2144613
Title:
Methods Of Altering Bone Growth By Administration Of Sost Or Wise Antagonist Or Agonist
Applicant:
OSSIFI-MAB LLC
Opposition Date:
Dec 21, 2018
Patent Number:
EP2606142
Title:
Method For Inactivating Proteases By Ph Change In A Liquid Obtained From A Cell Culture
Applicant:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Opposition Date:
Nov 28, 2018
Patent Number:
EP2586788
Title:
Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides
Applicant:
GENENTECH, INC.
Opposition Date:
Aug 29, 2018
Patent Number:
EP2794652
Title:
Rapid Method For Cloning And Expression Of Cognate Antibody Variable Region Gene Segments
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Aug 15, 2018

Latest patents of Ucb Biopharma Srl opposed by its competitors

Patent:
EP3717631
Grant Date:
Aug 30, 2023
Title:
Cell Culture Methods
Oppositions:
2
Patent:
EP3311168
Grant Date:
May 10, 2023
Title:
Novel Tnf Structure For Use In Therapy
Oppositions:
1
Patent:
EP2515887
Grant Date:
Jun 6, 2018
Title:
Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of Rotigotine
Oppositions:
2

Competitors of Ucb Biopharma Srl

GENENTECH, INC.

BIOARCTIC AB

BIOARCTIC NEUROSCIENCE AB

Want to track Ucb Biopharma Srl?

Feel free to send us a message here and we will get back to you